Palla Pharma Limited (ASX:PAL)


right-arrow Created with Sketch. 0 (0%)
MCAP $61.52M
Last trade 15.51pm 07/12/2021 20mins delayed

Latest Announcements

26/11/2021 Price SensitivePSPALPalla Pharma Limited
08/11/2021PALPalla Pharma Limited
05/10/2021PALPalla Pharma Limited
04/10/2021PALPalla Pharma Limited
30/09/2021 Price SensitivePSPALPalla Pharma Limited
30/09/2021PALPalla Pharma Limited
22/09/2021PALPalla Pharma Limited
09/09/2021PALPalla Pharma Limited

Company Overview

Palla Pharma Limited is an Australia-based vertically integrated pharmaceutical company. The Company's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The Company operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The Company has developed a water-based extraction technology, which is used in NRM production. It sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.

PAL in the news

Palla Pharma (PAL) enters into a sale and leaseback agreement of its…
Palla Pharma (PAL) has appointed Giles Moss to the role of Chief…
Palla Pharma (PAL) has formally launched its Co-Codamol 30/500 caplet in the…
Pharmaceutical company Palla Pharma (PAL) has raised roughly $12.24 million via a…

Search Previous Announcements